Treatment options for myeloma have expanded in.
Multiple myeloma stem cell transplant success rate.
For an autologous stem cell transplant the.
Older patients and those with low risk disease show the greatest gains over time while people with high risk factors showed the least change its researchers said.
Before the transplant drug treatment is used to reduce the number of myeloma cells in the patient s body.
We here analyze factors influencing survival in 865 newly diagnosed mm patien.
The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival.
Autologous stem cell transplantation autosct has an important role in the treatment of patients with symptomatic multiple myeloma mm.
See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic.
There can be a long period of dormancy that could.
The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review study reports.
In some cases a bone marrow or stem cell transplant is an option.